Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

(ALKS 4230-007/GOG-3063) A Phase 3, Multicenter, Open-Label, Randomized Study of Nemvaleukin Alfa in Combination With Pembrolizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARTISTRY-7)

  • Details

ClinicalTrials.gov ID: NCT05092360
Diagnosis Type: Peritoneal Cancer
USOR Number: 21457

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 683-5001

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A multi-site, open-label, Phase II, randomized, controlled trial to compare the efficacy of RO7198457 versus watchful waiting in resected, Stage II (high risk) and Stage III colorectal cancer patients who are ctDNA positive following resection (BNT122-01)

  • Details

ClinicalTrials.gov ID: NCT04486378
Diagnosis Type: Rectal Cancer
USOR Number: 21386

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

Epidemiological study to determine the prevalence of ctDNA positivity in participants with Stage II (high risk) or Stage III CRC after surgery with curative (R0) intent and subsequent adjuvant chemotherapy with monitoring of ctDNA during clinical follow-up (BNT000-001)

  • Details

ClinicalTrials.gov ID: NCT04813627
Diagnosis Type: Rectal Cancer
USOR Number: 21385

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

AN OPEN-LABEL, MULTICENTER, PHASE II TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF SUBCUTANEOUS MOSUNETUZUMAB MONOTHERAPY IN PATIENTS WITH SELECT B-CELL MALIGNANCIES (ML43389)

  • Details

ClinicalTrials.gov ID: NCT05207670
Diagnosis Type: Lymphomas
USOR Number: 21356

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A PHASE 1B/2 BASKET STUDY OF ACR-368 AS MONOTHERAPY AND IN COMBINATION WITH GEMCITABINE IN ADULT SUBJECTS WITH PLATINUM-RESISTANT OVARIAN CARCINOMA, ENDOMETRIAL ADENOCARCINOMA, AND UROTHELIAL CARCINOMA BASED ON ACRIVON ONCOSIGNATURE STATUS (ACR-368-201/GOG-3082)

  • Details

ClinicalTrials.gov ID: NCT05548296
Diagnosis Type: Urothelial Cancer
USOR Number: 21353

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A PHASE I-III, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE THERAPIES IN COHORTS OF PATIENTS SELECTED ACCORDING TO BIOMARKER STATUS, WITH LOCALLY ADVANCED, UNRESECTABLE, STAGE III NON-SMALL CELL LUNG CANCER (BO42777)

  • Details

ClinicalTrials.gov ID: NCT05170204
Diagnosis Type: Lung Cancer
USOR Number: 21318

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A PHASE I-III, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE THERAPIES IN COHORTS OF PATIENTS SELECTED ACCORDING TO BIOMARKER STATUS, WITH LOCALLY ADVANCED, UNRESECTABLE, STAGE III NON-SMALL CELL LUNG CANCER (BO42777)

  • Details

ClinicalTrials.gov ID: NCT05170204
Diagnosis Type: Lung Cancer
USOR Number: 21318

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.(950P1V02)

  • Details

ClinicalTrials.gov ID: NCT03872947
Diagnosis Type: Peritoneal Cancer
USOR Number: 21304

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.(950P1V02)

  • Details

ClinicalTrials.gov ID: NCT03872947
Diagnosis Type: Peritoneal Cancer
USOR Number: 21304

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ZN-c3-005| GOG 3066)

  • Details

ClinicalTrials.gov ID: NCT05128825
Diagnosis Type: Peritoneal Cancer
USOR Number: 21270

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page
1 2 3 4 5

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.